Press Releases
(EMAILWIRE.COM, September 10, 2018 ) United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.
“Pediatric...more
(EMAILWIRE.COM, September 10, 2018 ) Vaccines: The End of Illness Executive Summary
Vaccines are probably the most effective discovery in the history of medical science. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part...more
(EMAILWIRE.COM, September 10, 2018 ) The Human Microbiome: Biomedical Implications and Birth of a Market - Executive Summary
Results from the Human Microbiome Project and other massive studies of human bacterial symbionts, which far outnumber human cells in the body, have drawn lots of attention...more
(EMAILWIRE.COM, September 10, 2018 ) Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks Overview(2)
Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks delves into the rapidly evolving...more
(EMAILWIRE.COM, September 10, 2018 ) Biomanufacturing Capacity Strategies - Biomanufacturing Capacity Strategies: developing a flexible, scalable and lean biomanufacturing system has a focus on the need for a more reactive and dynamic biomanufacturing approach than is the current industry standard....more
(EMAILWIRE.COM, September 10, 2018 ) Insight Pharma Reports’ Gene Therapy: Moving Toward Commercialization”, outlines the progress of the gene therapy field since its inception in the 1970s, with a special focus on clinical-stage gene therapy programs that are aimed at commercialization, and the...more
(EMAILWIRE.COM, September 10, 2018 ) Recombinant antibodies have been the shining jewel in the firmament of the pharma industry for almost the last two decades. They have returned billions of dollars in sales, and if their performance has not been the unalloyed triumph that was foreseen at their...more
(EMAILWIRE.COM, September 10, 2018 ) Marketing to Life Scientists: Second Edition
Marketing Studies Second EditionAs marketers, we all have the same struggles – whether it is not being able to get our messages in front of our customers or prospects or not delivering enough leads to our sales team,...more
(EMAILWIRE.COM, September 10, 2018 ) Commercializing Novel IVDs: A Comprehensive Manual for Success
Does your company have an idea for a novel biomarker test, but you’re unsure what the market potential will be?
Have you invented a more sensitive test to diagnose a common autoimmune disorder,...more
(EMAILWIRE.COM, September 10, 2018 ) Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes
This new report builds on our 2014 Insight Pharma Report, Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies. In that report, we focused...more
